Difference between revisions of "Team:ETH Zurich/Achievements"

Line 28: Line 28:
 
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Genetic_circuit">genetic circuit</a> that integrates two different cancer specific signals (<a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">lactate </a>and <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module">AHL</a>)in an <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Combined_Model#Combined_Model">AND gate</a>.</li>
 
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Design#Genetic_circuit">genetic circuit</a> that integrates two different cancer specific signals (<a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Lactate_Module">lactate </a>and <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/AHL_Module">AHL</a>)in an <a href="https://2015.igem.org/Team:ETH_Zurich/Modeling/Combined_Model#Combined_Model">AND gate</a>.</li>
  
<li>We found a method to do single cell analysis by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview">expressing a protein (Annexin V) on the E. coli membrane</a> that makes them stick to apoptotic mammalian cells.</li></ul>
+
<li>We implemented a method to do single cell analysis of cancer cells by <a href="https://2015.igem.org/Team:ETH_Zurich/Design#System_Overview">expressing Annexin V on the <i>E. coli</i> membrane</a> that makes them stick to apoptotic mammalian cells.</li></ul>
  
 
<p></p>
 
<p></p>
Line 36: Line 36:
 
<ul><li>We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a very limited amount of information present in the literature.</li>
 
<ul><li>We characterized parts of the natural <i>E. coli</i> <a href="https://2015.igem.org/Team:ETH_Zurich/Results#Characterization_of_the_LldR_promoter">lldPRD-operon</a>, on which there is only a very limited amount of information present in the literature.</li>
  
<li>We characterized many <a href="https://2015.igem.org/Team:ETH_Zurich/Parts">parts</a> and determined many parameters of our system performing various <a href="https://2015.igem.org/Team:ETH_Zurich/Experiments">experiments.</a></li>
+
<li>We design x synthetic lldR dependent promoters and characterized them (additionally the influence of the lacate importer llDP was characterized)</li>
  
 
<li>We documented and submitted XX new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with XX parts.</li>
 
<li>We documented and submitted XX new <a href="https://2015.igem.org/Team:ETH_Zurich/Basic_Part">basic parts</a> to the iGEM parts registry and created a <a href="https://2015.igem.org/Team:ETH_Zurich/Part_Collection">part collection</a> with XX parts.</li>
  
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon E. coli.</li>
+
<li>We designed a <a href="https://2015.igem.org/Team:ETH_Zurich/Chip">chip</a> for later easy application of our MicroBeacon <i>E. coli</i>.</li>
  
 
<li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li>
 
<li>We participated in the <a href="https://2015.igem.org/Team:ETH_Zurich/Interlab_study">interlab study</a>.</li>
Line 55: Line 55:
 
<h3>Human Practices Achievements</h3>
 
<h3>Human Practices Achievements</h3>
  
<ul><li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a>with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li>
+
<ul><li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Stockholm">collaborated</a> with the team from <a href="https://2015.igem.org/Team:Stockholm"> Stockholm</a> by testing some of their constructs.</li>
  
 
<li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li>
 
<li>We <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Amoy">contributed</a> to the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">Newsletters</a> from <a href="https://2015.igem.org/Team:Amoy#">Amoys team</a>, met with the <a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt team</a>, helped with a survey from <a href="https://2015.igem.org/Team:EPF_Lausanne">EPFL</a> and provided <a href="https://2015.igem.org/Team:Uniandes_Colombia">Colombias team</a> with protocols and <a href="https://2015.igem.org/Team:ETH_Zurich/Collaborations#Colombia">advice</a> when their transformations did not work.</li>

Revision as of 09:50, 14 September 2015

"What I cannot create I do not understand."
- Richard Feynmann

Achievements

We are proud to announce that we achieved the following goals

General Achievements

Experimental Achievements

  • We characterized parts of the natural E. coli lldPRD-operon, on which there is only a very limited amount of information present in the literature.
  • We design x synthetic lldR dependent promoters and characterized them (additionally the influence of the lacate importer llDP was characterized)
  • We documented and submitted XX new basic parts to the iGEM parts registry and created a part collection with XX parts.
  • We designed a chip for later easy application of our MicroBeacon E. coli.
  • We participated in the interlab study.
  • We attended the safety instrucions from the department D-BSSE in basel where we have our lab.

Modeling Achievements

Human Practices Achievements

Medal Criteria

Register for iGEM, have a great summer, and attend the Giant Jamboree. Going for it!
Complete the Judging form
Create a Description of the team's project
Document the team's parts using the Registry of Standard Biological Parts
Present a poster and a talk at the iGEM Jamboree. Going for it!
Create a page on your team wiki with clear attribution of each aspect of your project.
Document one new standard BioBrick Part or Device
Experimentally validate that at least one new BioBrick Part of your own design
Submit this new part to the iGEM Parts Registry.
Human Practices in iGEM. Demonstrate how your team has identified, investigated and addressed one or more of these issues in the context of your project.
Expand on your silver medal Human Practices activity
Help another university to characterize a part
Improve the characterization of a previously existing BioBrick Part or Device

We would like to thank our sponsors